Condition
Pulmonary Hypertension (PH)
Total Trials
4
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting3
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07676786Not Yet RecruitingPrimary
Euvolemia-Based Assessment of Pulmonary Hypertension in Stable Hemodialysis Patients
NCT07537517Recruiting
Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.
NCT07522203Recruiting
Arterial Wave Energy Flux and Multidimensional Recovery in Patients With Chronic Thromboembolic Pulmonary Hypertension Undergoing Balloon Pulmonary Angioplasty
NCT01347216Recruiting
COMPERA / COMPERA-KIDS
Showing all 4 trials